These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 9466983)

  • 1. Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents.
    Koenig A; Norgard-Sumnicht K; Linhardt R; Varki A
    J Clin Invest; 1998 Feb; 101(4):877-89. PubMed ID: 9466983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial heparan sulfate proteoglycans that bind to L-selectin have glucosamine residues with unsubstituted amino groups.
    Norgard-Sumnicht K; Varki A
    J Biol Chem; 1995 May; 270(20):12012-24. PubMed ID: 7538130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tunicate Heparan Sulfate Enriched in 2-Sulfated β-Glucuronic Acid: Structure, Anticoagulant Activity, and Inhibitory Effect on the Binding of Human Colon Adenocarcinoma Cells to Immobilized P-Selectin.
    Abreu WS; Soares PAG; Motta JM; Kozlowski EO; Teixeira FCOB; Soares MA; Borsig L; Mourão PAS; Pavão MSG
    Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31212795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential metastasis inhibition by clinically relevant levels of heparins--correlation with selectin inhibition, not antithrombotic activity.
    Stevenson JL; Choi SH; Varki A
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):7003-11. PubMed ID: 16203794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparan sulfate and chondroitin sulfate proteoglycans inhibit E-selectin binding to endothelial cells.
    Luo J; Kato M; Wang H; Bernfield M; Bischoff J
    J Cell Biochem; 2001; 80(4):522-31. PubMed ID: 11169736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties.
    Harris N; Kogan FY; Il'kova G; Juhas S; Lahmy O; Gregor YI; Koppel J; Zhuk R; Gregor P
    Biochim Biophys Acta; 2014 Jan; 1840(1):245-54. PubMed ID: 24060749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
    Vischer P; Feitsma K; Schön P; Völker W
    Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of L-selectin binding heparan sulfates attached to collagen type XVIII.
    Celie JW; Keuning ED; Beelen RH; Dräger AM; Zweegman S; Kessler FL; Soininen R; van den Born J
    J Biol Chem; 2005 Jul; 280(29):26965-73. PubMed ID: 15917223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium-dependent heparin-like ligands for L-selectin in nonlymphoid endothelial cells.
    Norgard-Sumnicht KE; Varki NM; Varki A
    Science; 1993 Jul; 261(5120):480-3. PubMed ID: 7687382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selectin blocking activity of a fucosylated chondroitin sulfate glycosaminoglycan from sea cucumber. Effect on tumor metastasis and neutrophil recruitment.
    Borsig L; Wang L; Cavalcante MC; Cardilo-Reis L; Ferreira PL; Mourão PA; Esko JD; Pavão MS
    J Biol Chem; 2007 May; 282(20):14984-91. PubMed ID: 17371880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified heparin inhibits P-selectin-mediated cell adhesion of human colon carcinoma cells to immobilized platelets under dynamic flow conditions.
    Wei M; Tai G; Gao Y; Li N; Huang B; Zhou Y; Hao S; Zeng X
    J Biol Chem; 2004 Jul; 279(28):29202-10. PubMed ID: 15133030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44.
    Kawashima H; Hirose M; Hirose J; Nagakubo D; Plaas AH; Miyasaka M
    J Biol Chem; 2000 Nov; 275(45):35448-56. PubMed ID: 10950950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro model for hematopoietic progenitor cell homing reveals endothelial heparan sulfate proteoglycans as direct adhesive ligands.
    Netelenbos T; van den Born J; Kessler FL; Zweegman S; Huijgens PC; Drager AM
    J Leukoc Biol; 2003 Dec; 74(6):1035-44. PubMed ID: 14525970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of thrombospondin-1 and heparan sulfate from endothelial cells. Structural requirements of heparan sulfate.
    Feitsma K; Hausser H; Robenek H; Kresse H; Vischer P
    J Biol Chem; 2000 Mar; 275(13):9396-402. PubMed ID: 10734084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin also interacts with selectins and modulates the cell adhesion process.
    Yanaka K; Kato N; Nose T
    Circulation; 2000 Nov; 102(20):E169. PubMed ID: 11076839
    [No Abstract]   [Full Text] [Related]  

  • 16. Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer.
    Casu B; Naggi A; Torri G
    Matrix Biol; 2010 Jul; 29(6):442-52. PubMed ID: 20416374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of low sulfated heparan sulfate sequences with affinity for lipoprotein lipase.
    Spillmann D; Lookene A; Olivecrona G
    J Biol Chem; 2006 Aug; 281(33):23405-13. PubMed ID: 16782967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium.
    Kim YJ; Borsig L; Han HL; Varki NM; Varki A
    Am J Pathol; 1999 Aug; 155(2):461-72. PubMed ID: 10433939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor A chain.
    Feyzi E; Lustig F; Fager G; Spillmann D; Lindahl U; Salmivirta M
    J Biol Chem; 1997 Feb; 272(9):5518-24. PubMed ID: 9038157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic interactions of the two classes of ligand, sialyl-Lewis(a/x) fuco-oligosaccharides and short sulpho-motifs, with the P- and L-selectins: implications for therapeutic inhibitor designs.
    Galustian C; Childs RA; Stoll M; Ishida H; Kiso M; Feizi T
    Immunology; 2002 Mar; 105(3):350-9. PubMed ID: 11918697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.